    <SEC-DOCUMENT>0001764013-24-000116-index.html : 20240626
    <SEC-HEADER>0001764013-24-000116.hdr.sgml : 20240626
    <ACCEPTANCE-DATETIME>20240626070121
    ACCESSION NUMBER:		0001764013-24-000116
    CONFORMED SUBMISSION TYPE:	DEFA14A
    PUBLIC DOCUMENT COUNT:		3
    FILED AS OF DATE:		20240626
    DATE AS OF CHANGE:		20240626

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Immunovant, Inc.
    		CENTRAL INDEX KEY:			0001764013
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				832771572
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			0331

    	FILING VALUES:
    		FORM TYPE:		DEFA14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38906
    		FILM NUMBER:		241070600

    	BUSINESS ADDRESS:
    		STREET 1:		320 WEST 37TH STREET
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10018
    		BUSINESS PHONE:		917-580-3099

    	MAIL ADDRESS:
    		STREET 1:		320 WEST 37TH STREET
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10018

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Health Sciences Acquisitions Corp
    		DATE OF NAME CHANGE:	20190108
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEFA14A
    <SEQUENCE>1
    <FILENAME>defa14aadditionalmaterials.htm
    <DESCRIPTION>DEFA14A
    <TEXT>
    Document 1 - file: defa14aadditionalmaterials.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>immunovantinc_vxnaxp14830xb.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 2 - file: immunovantinc_vxnaxp14830xb.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>immunovantinc_vxnaxp14830xc.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 3 - file: immunovantinc_vxnaxp14830xc.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>